Spirendolol
С Википедије, слободне енциклопедије
| |
| Nazivi | |
|---|---|
| IUPAC naziv
4-[3-(tert-Butilamino)-2-hidroksipropoksi]spiro[3H-inden-2,1'-cikloheksan]-1-on
| |
| Identifikacija | |
3D model (Jmol)
|
|
| ChemSpider | |
| UNII | |
| |
| Svojstva | |
| C21H31NO3 | |
| Molarna masa | 345,48 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose nastandardno stanjematerijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Spirendololjeantagonist beta adrenergičkog receptora.[3]
Reference
[уреди|уреди извор]- ^Li Q, Cheng T, Wang Y, Bryant SH (2010).„PubChem as a public resource for drug discovery.”.Drug Discov Today.15(23-24): 1052—7.PMID20970519.doi:10.1016/j.drudis.2010.10.003.уреди
- ^Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry.4:217—241.doi:10.1016/S1574-1400(08)00012-1.
- ^Mostaghim, R; Maddox, YT; Ramwell, PW (1986). „Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents”.The Journal of Pharmacology and Experimental Therapeutics.239(3): 797—801.PMID2879033.